Log in to save to my catalogue

Clioquinol inhibits dopamine-β-hydroxylase secretion and noradrenaline synthesis by affecting the re...

Clioquinol inhibits dopamine-β-hydroxylase secretion and noradrenaline synthesis by affecting the re...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2478285369

Clioquinol inhibits dopamine-β-hydroxylase secretion and noradrenaline synthesis by affecting the redox status of ATOX1 and copper transport in human neuroblastoma SH-SY5Y cells

About this item

Full title

Clioquinol inhibits dopamine-β-hydroxylase secretion and noradrenaline synthesis by affecting the redox status of ATOX1 and copper transport in human neuroblastoma SH-SY5Y cells

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Archives of toxicology, 2021-01, Vol.95 (1), p.135-148

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Clioquinol (5-chloro-7-indo-8-quinolinol), a chelator and ionophore of copper/zinc, was extensively used as an amebicide to treat indigestion and diarrhea in the mid-1900s. However, it was withdrawn from the market in Japan because its use was epidemiologically linked to an increase in the incidence of subacute myelo-optic neuropathy (SMON). SMON i...

Alternative Titles

Full title

Clioquinol inhibits dopamine-β-hydroxylase secretion and noradrenaline synthesis by affecting the redox status of ATOX1 and copper transport in human neuroblastoma SH-SY5Y cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2478285369

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2478285369

Other Identifiers

ISSN

0340-5761,1432-0738

E-ISSN

1432-0738

DOI

10.1007/s00204-020-02894-0

How to access this item